: Novavax’s stock pops after WHO grants its COVID-19 vaccine emergency-use listing

Novavax Inc.’s stock rose 2% early Tuesday, after the company said its protein-based COVID-19 vaccine has been granted emergency-use listing by the World Health Organization.

The move means that all 194 of the agency’s member states can use the Novavax vaccine to protect against COVID in individuals 12 and older. The vaccine is already allowed in the U.S. under a similar emergency-use authorization.


Master your money.

Subscribe to MarketWatch.

Get this article and all of MarketWatch.

Access from any device. Anywhere. Anytime.

Subscribe Now

This post was originally published on MarketWatch

Share your love